EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential Promoter Methylation of MMP-9 and E-Cadherin Genes in CLL: Evidence for a Pathogenic Role of MMP-9 Hypomethylation

Zeki Ali Mohamed

Journal of Molecular Pathology · 23.03.2026 · 7 (1) · 14

DOI: 10.3390/jmp7010014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Pathology, online erschienen am 23.03.2026. Verfasst von Zeki Ali Mohamed. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Chronic lymphocytic leukemia (CLL) is characterized by genetic and epigenetic alterations. This study aimed to assess the methylation status of E-Cadherin and MMP-9 gene promoters and to explore their relationships with disease pathogenesis and hematological parameters in CLL patients.

Methods

A case–control study was conducted with 70 newly diagnosed CLL patients and 70 age- and sex-matched healthy controls. Promoter methylation of E-Cadherin and MMP-9 genes was evaluated using methylation-specific PCR (MSP) and methylation-sensitive restriction enzyme PCR (MSRE-PCR), respectively.

Results

The median patient age was 62 years, and 68.5% were males. Binet stage A was the most common stage (57.3%). E-Cadherin promoter methylation was detected in 75.7% of CLL patients and 77.1% of controls (p = 0.91), showing no significant association with disease occurrence; however, it showed a significant correlation with higher lymphocyte counts (p = 0.01). In contrast, MMP-9 promoter methylation was significantly less frequent in CLL cases (70.0%) than in controls (100%, p = 0.001). Unmethylated MMP-9 correlated significantly with female gender (p = 0.02), lower hemoglobin (p = 0.031), reduced platelet counts (p = 0.001), and higher lymphocyte counts (p = 0.035).

Conclusions

MMP-9 promoter hypomethylation may play a pathogenic role in CLL and is associated with female gender and cytopenia, whereas E-Cadherin methylation appears to be non-specific. MMP-9 methylation status could therefore serve as a potential biomarker for CLL biology and prognosis.

Zitieren

APA

Mohamed, Z. A. (2026). Differential Promoter Methylation of MMP-9 and E-Cadherin Genes in CLL: Evidence for a Pathogenic Role of MMP-9 Hypomethylation. Journal of Molecular Pathology, 7(1), 14. https://doi.org/10.3390/jmp7010014

Vancouver

Mohamed ZA. Differential Promoter Methylation of MMP-9 and E-Cadherin Genes in CLL: Evidence for a Pathogenic Role of MMP-9 Hypomethylation. Journal of Molecular Pathology. 2026;7(1):14. doi:10.3390/jmp7010014

BibTeX
@article{Mohamed2026,
  author = {Mohamed, Zeki Ali},
  title = {Differential Promoter Methylation of MMP-9 and E-Cadherin Genes in CLL: Evidence for a Pathogenic Role of MMP-9 Hypomethylation},
  journal = {Journal of Molecular Pathology},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {14},
  doi = {10.3390/jmp7010014}
}
Kostenlos starten →